Mbf 20logo 20offset
Logo 20abbreviated

MBF Therapeutics

Developing innovative turbo-charged infectious disease and cancer vaccines for the animal health market using gene based check point inhibitors.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Ambler, PA, US
  • Currency USD
  • Founded June 2008
  • Employees 4
  • Incorporation Type C-corp
  • Website mbftherapeutics.com

Company Summary

MBFT is a clinical-stage animal health company developing check-point inhibitor (cpi) immunotherapeutic vaccines. CPIs are the fast-growing field in immunotherapy. Using a proprietary platform technology, we are developing multiple innovative immunotherapies for infectious disease and cancer. Markets are projected are to be worth more than $8B. Keiretsu Forum Mid-Atlantic has completed due diligence, the report is available upon request.

Team

  • 3060f00a a6f7 4f64 95d1 e65313a4fc14
    Founder & CEO

    CEO of RHeoGene. Started the company in 1999 as a JV between Rohm & Haas and Argonex. In 2003, he led the highly innovative and unique effort to donate the IP and material assets of RHeoGene to the UPMC. As RheoGene CEO, he and his team established an innovative clinical development program with the RheoSwitch® Therapeutic System (RTS) that has led to the first human clinical trial of a small molecule-induced gene regulation system.

  • 7366fd8f 5cf6 464e ba00 7059c761bd25
    Chief Scientific Officer

    Founder & VP Marketing and Communications @ RheoGene
    Co-founder Immunotope
    Portfolio Manager, Biostrategy Partners
    Rohm and Haas Co.

  • D2987a45 e675 43c4 995f a2a7b1fb7c8b
    Chief Medical Officer

    CEO at Prairie Diagnostic Services, Inc., a full service veterinary diagnostic laboratory
    Chief Medical Officer at Premune
    Schering-Plough Animal Health, Pfizer AH (international HQ), Intervet, Inc., Baxter HealthCare and Merial
    DVM from Cornell University

  • 276d705c 8e98 455c 93a7 eb57fd920fe5
    Executive Vice President Business Development

    President of Amlan International the Animal Health and Nutrition Division of family owned publicly traded sorbent mineral company from Chicago, Illinois.
    NOVARTIS ANIMAL VACCINES INC., President & CEO
    PFIZER ANIMAL HEALTH Marketing Director/Senior Marketing Manger, Global Biologicals
    SMITHKLINE BEECHAM ANIMAL HEALTH Director, Worldwide Strategic Product Development

Previous Investors

  • Default avatar
    Ben Franklin Technology Partners SEPA
    Unconfirmed
    Default avatar
    Chris Cashman
    Unconfirmed
    Default avatar
    Gerald McNamara
    Unconfirmed